Turning crisis into opportunity: a Canadian-made bio-revolution

Canada has a second chance to build a comprehensive biotech ecosystem as new domestic investment funds and foreign investors take notice of our industry.
A well-supported Canadian life sciences and biotechnology industry requires thoughtful partnerships, much more investment and a transparent regulatory path for novel technologies, says Bettina Hamelin, president and CEO of Ontario Genomics.
Twenty years after the Human Genome Project, we have made significant strides in understanding what “genomics” can do to transform health care. Today, genomics pave the way for a bio-revolution that reaches far beyond human health into crop optimization, food production, and the sustainable manu...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE Opinion

RELATED STORIES